Contemporary Resource Use and Costs Among Patients With Medically Managed Severe Aortic Stenosis: Results From a US National Claims Database
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.041889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Adam S Vohra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Cardiology University of Chicago Medicine Chicago IL USA. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Health Care Costs, Health Resources. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Patients with severe aortic stenosis (AS) who are managed medically have a poor prognosis. No contemporary studies have examined resource use and costs associated with medical management for severe AS.
Methods
Using the Optum Market Clarity Database, which links electronic health records with cost and use data, we identified patients with documented severe AS between 2016 and 2020 who were eligible for aortic valve replacement but did not undergo treatment within 1 year following diagnosis. Outcomes included health care resource use and costs during the 4‐year period following the initial diagnosis. Fine‐Gray competing risk models estimated use rates, and the Bang‐Tsiatis method quantified use and costs while accounting for censoring.
Results
Over the study period, 6892 patients presented with severe AS, of whom 3334 (48%) were managed medically and 2812 (41%) were similar (based on propensity matching) to those who underwent aortic valve replacement. Over 4 years of follow‐up, these patients experienced an average of 1.99 hospitalizations, 1.33 of which were related to a cardiovascular condition. Total costs (including hospitalizations, outpatient care, and pharmacy services) were $126 638 per patient, of which $56 032 was for inpatient care, $31 603 was for outpatient care, and $21 160 was for pharmacy services.
Conclusions
In contemporary practice, despite the availability of effective treatment, many patients with severe AS do not undergo aortic valve replacement within the year after diagnosis. These patients with severe AS who are managed medically experience high health care‐related resource use and costs. Further research is needed to identify factors associated with lack of timely aortic valve replacement and to address barriers to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Section of Cardiology University of Chicago Medicine Chicago IL USA.
- Edwards Lifesciences Irvine CA USA.
- Cardiovascular Research Foundation New York NY USA.
- St. Francis Hospital Roslyn NY USA.
ORCID-Profile: Adam S Vohra, Shannon M E Murphy, Christin A Thompson, David J Cohen
Zitieren
APA
Vohra, A. S., Murphy, S. M. E., Thompson, C. A., & Cohen, D. J. (2025). Contemporary Resource Use and Costs Among Patients With Medically Managed Severe Aortic Stenosis: Results From a US National Claims Database. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041889
Vancouver
Vohra AS, Murphy SME, Thompson CA, Cohen DJ. Contemporary Resource Use and Costs Among Patients With Medically Managed Severe Aortic Stenosis: Results From a US National Claims Database. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041889
BibTeX
@article{Vohra2025,
author = {Vohra, Adam S and Murphy, Shannon M E and Thompson, Christin A and Cohen, David J},
title = {Contemporary Resource Use and Costs Among Patients With Medically Managed Severe Aortic Stenosis: Results From a US National Claims Database},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041889}
}
EUVIMED